{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:45:13Z","timestamp":1789911913375,"version":"4.0.1"},"reference-count":123,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation Research"],"published-print":{"date-parts":[[2014,6,6]]},"abstract":"<jats:p>Acute coronary syndromes (ACS) constitute a spectrum of clinical presentations ranging from unstable angina and non\u2013ST-segment elevation myocardial infarction to ST-segment myocardial infarction. Myocardial ischemia in this context occurs as a result of an abrupt decrease in coronary blood flow and resultant imbalance in the myocardial oxygen supply\u2013demand relationship. Coronary blood flow is further compromised by other mechanisms that increase coronary vascular resistance or reduce coronary driving pressure. The goals of treatment are to decrease myocardial oxygen demand, increase coronary blood flow and oxygen supply, and limit myocardial injury. Treatments are generally divided into disease-modifying agents or interventions that improve hard clinical outcomes and other strategies that can reduce ischemia. In addition to traditional drugs such as \u03b2-blockers and inhibitors of the renin\u2013angiotensin\u2013aldosterone system, newer agents have expanded the number of molecular pathways targeted for treatment of ACS. Ranolazine, trimetazidine, nicorandil, and ivabradine are medications that have been shown to reduce myocardial ischemia through diverse mechanisms and have been tested in limited fashion in patients with ACS. Attenuating the no-reflow phenomenon and reducing the injury compounded by acute reperfusion after a period of coronary occlusion are active areas of research. Additionally, interventions aimed at ischemic pre- and postconditioning may be useful means by which to limit myocardial infarct size. Trials are also underway to examine altered metabolic and oxygen-related pathways in ACS. This review will discuss traditional and newer anti-ischemic therapies for patients with ACS, exclusive of revascularization, antithrombotic agents, and the use of high-intensity statins.<\/jats:p>","DOI":"10.1161\/circresaha.114.302804","type":"journal-article","created":{"date-parts":[[2014,6,5]],"date-time":"2014-06-05T20:28:43Z","timestamp":1402000123000},"page":"1944-1958","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":21,"title":["Nonantithrombotic Medical Options in Acute Coronary Syndromes"],"prefix":"10.1161","volume":"114","author":[{"given":"Victor","family":"Soukoulis","sequence":"first","affiliation":[{"name":"From the Cardiovascular Division, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA (V.S., P.T.O.); Division of Cardiology, Department of Medicine, Albany Stratton Veteran\u2019s Affairs Medical Centre and Albany Medical College, NY (W.E.B.); and Division of Cardiology, University of North Carolina, Chapel Hill (S.C.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Boden","sequence":"additional","affiliation":[{"name":"From the Cardiovascular Division, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA (V.S., P.T.O.); Division of Cardiology, Department of Medicine, Albany Stratton Veteran\u2019s Affairs Medical Centre and Albany Medical College, NY (W.E.B.); and Division of Cardiology, University of North Carolina, Chapel Hill (S.C.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Sidney C.","family":"Smith","sequence":"additional","affiliation":[{"name":"From the Cardiovascular Division, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA (V.S., P.T.O.); Division of Cardiology, Department of Medicine, Albany Stratton Veteran\u2019s Affairs Medical Centre and Albany Medical College, NY (W.E.B.); and Division of Cardiology, University of North Carolina, Chapel Hill (S.C.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick T.","family":"O\u2019Gara","sequence":"additional","affiliation":[{"name":"From the Cardiovascular Division, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA (V.S., P.T.O.); Division of Cardiology, Department of Medicine, Albany Stratton Veteran\u2019s Affairs Medical Centre and Albany Medical College, NY (W.E.B.); and Division of Cardiology, University of North Carolina, Chapel Hill (S.C.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","first-page":"1049","volume-title":"Braunwald's Heart Disease. A Textbook of Cardiovascular Medicine","author":"Canty JM","year":"2011","unstructured":"Canty JM. Coronary blood flow and myocardial ischemia. In: , Bonow RO, Mann DL, Zipes DP, Libby P Braunwald's Heart Disease. A Textbook of Cardiovascular Medicine. Elsevier Health Sciences: Philadelphia, PA; 2011:1049\u20131075."},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1983.63.1.1"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1216063"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-75434-5_3"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(99)00074-1"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(96)00472-X"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-159-11-201312030-00007"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.113.300987"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000016602.96363.36"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvr358"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.107.702993"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.74.5.1124"},{"key":"e_1_3_4_14_2","first-page":"H1306","article-title":"Four brief periods of myocardial ischemia cause no cumulative ATP loss or necrosis.","volume":"251","author":"Reimer KA","year":"1986","unstructured":"Reimer KA, Murry CE, Yamasawa I, Hill ML, Jennings RB. Four brief periods of myocardial ischemia cause no cumulative ATP loss or necrosis. Am J Physiol. 1986;251:H1306\u2013H1315.","journal-title":"Am J Physiol"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.108.843474"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.188950"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hfc.2012.12.010"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hfc.2012.12.015"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199207233270406"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.318.7200.1730"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2007.04.016"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.12559"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67661-1"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e3182742c84"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0b013e318212bb8b"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e318256f1e0"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e318235eb4d"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs215"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr236"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.110.944603"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)91906-X"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90865-X"},{"key":"e_1_3_4_33_2","first-page":"1115","article-title":"GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction.","volume":"343","author":"Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019infarto Miocardico","year":"1994","unstructured":"Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet. 1994;343:1115\u20131122.","journal-title":"Lancet"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(90)90351-Z"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.56.5.400"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.299.6709.1187"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2009.12"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199209033271001"},{"key":"e_1_3_4_39_2","first-page":"821","article-title":"Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure.","volume":"342","author":"The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators","year":"1993","unstructured":"The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 1993;342:821\u2013828.","journal-title":"Lancet"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512213332503"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02212-1"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200001203420301"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14286-9"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042739"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(01)01461-8"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.129.1_suppl.169S"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09895-1"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032292"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030207"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2005.078790"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.105.597500"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61554-8"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.16.1775"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.107.724880"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eus380"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.107.763912"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5922.2011.00275.x"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.86.5.580"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1159\/000139070"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.2165\/00129784-200707020-00006"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2006.107524"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1253\/circj.70.1169"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0066-782X2011005000079"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.1999.2439"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003614.pub2"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200060040-00007"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.2165\/11592300-000000000-00000"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00539-2"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08265-X"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-09-0649"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1987.127"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2007.04.019"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.1998.1354"},{"key":"e_1_3_4_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61634-1"},{"key":"e_1_3_4_75_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200464160-00003"},{"key":"e_1_3_4_76_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi586"},{"key":"e_1_3_4_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61170-8"},{"key":"e_1_3_4_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61198-1"},{"key":"e_1_3_4_79_2","doi-asserted-by":"publisher","DOI":"10.1177\/2048872613489305"},{"key":"e_1_3_4_80_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107898"},{"key":"e_1_3_4_81_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq299"},{"key":"e_1_3_4_82_2","doi-asserted-by":"publisher","DOI":"10.1161\/hc0502.102867"},{"key":"e_1_3_4_83_2","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.111.243170"},{"key":"e_1_3_4_84_2","doi-asserted-by":"publisher","DOI":"10.1177\/0300060513479859"},{"key":"e_1_3_4_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.03.054"},{"key":"e_1_3_4_86_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2006.05.010"},{"key":"e_1_3_4_87_2","first-page":"121","article-title":"The diagnosis and treatment of the no-reflow phenomenon in patients with myocardial infarction undergoing percutaneous coronary intervention.","volume":"13","author":"Ramjane K","year":"2008","unstructured":"Ramjane K, Han L, Jin C. The diagnosis and treatment of the no-reflow phenomenon in patients with myocardial infarction undergoing percutaneous coronary intervention. Exp Clin Cardiol. 2008;13:121\u2013128.","journal-title":"Exp Clin Cardiol"},{"key":"e_1_3_4_88_2","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.104.530329"},{"key":"e_1_3_4_89_2","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.112.300627"},{"key":"e_1_3_4_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.12.017"},{"key":"e_1_3_4_91_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.22.2259"},{"key":"e_1_3_4_92_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000087447.12918.85"},{"key":"e_1_3_4_93_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.1.43"},{"key":"e_1_3_4_94_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)00215-5"},{"key":"e_1_3_4_95_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01608-4"},{"key":"e_1_3_4_96_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.10.033"},{"key":"e_1_3_4_97_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.1.146"},{"key":"e_1_3_4_98_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr309"},{"key":"e_1_3_4_99_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.02.061"},{"key":"e_1_3_4_100_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2006.01.012"},{"key":"e_1_3_4_101_2","doi-asserted-by":"publisher","DOI":"10.1161\/circinterventions.112.000184"},{"key":"e_1_3_4_102_2","doi-asserted-by":"publisher","DOI":"10.1161\/circimaging.110.957340"},{"key":"e_1_3_4_103_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht369"},{"key":"e_1_3_4_104_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2013.06.007"},{"key":"e_1_3_4_105_2","first-page":"629","article-title":"Ischemic preconditioning: protection against myocardial necrosis and apoptosis.","volume":"3","author":"Iliodromitis EK","year":"2007","unstructured":"Iliodromitis EK, Lazou A, Kremastinos DT. Ischemic preconditioning: protection against myocardial necrosis and apoptosis. Vasc Health Risk Manag. 2007;3:629\u2013637.","journal-title":"Vasc Health Risk Manag"},{"key":"e_1_3_4_106_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60916-7"},{"key":"e_1_3_4_107_2","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.113.001690"},{"key":"e_1_3_4_108_2","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.113.300764"},{"key":"e_1_3_4_109_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.10.052"},{"key":"e_1_3_4_110_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa071142"},{"key":"e_1_3_4_111_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.110.167486"},{"key":"e_1_3_4_112_2","doi-asserted-by":"publisher","DOI":"10.1159\/000342981"},{"key":"e_1_3_4_113_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-007-9026-1"},{"key":"e_1_3_4_114_2","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.108.814640"},{"key":"e_1_3_4_115_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH12-05-0341"},{"key":"e_1_3_4_116_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2012.07.030"},{"key":"e_1_3_4_117_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.92.9.2367"},{"key":"e_1_3_4_118_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11278-5"},{"key":"e_1_3_4_119_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2004.08.033"},{"key":"e_1_3_4_120_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.4.437"},{"key":"e_1_3_4_121_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00054.2011"},{"key":"e_1_3_4_122_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-012-6413-1"},{"key":"e_1_3_4_123_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2013.02.005"},{"key":"e_1_3_4_124_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-012-0263-y"}],"container-title":["Circulation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCRESAHA.114.302804","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T03:58:23Z","timestamp":1715572703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCRESAHA.114.302804"}},"subtitle":["Old Agents and New Lines on the Horizon"],"short-title":[],"issued":{"date-parts":[[2014,6,6]]},"references-count":123,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,6,6]]}},"alternative-id":["10.1161\/CIRCRESAHA.114.302804"],"URL":"https:\/\/doi.org\/10.1161\/circresaha.114.302804","relation":{},"ISSN":["0009-7330","1524-4571"],"issn-type":[{"value":"0009-7330","type":"print"},{"value":"1524-4571","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,6]]},"assertion":[{"value":"2014-02-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-03-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-06-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}